CIPLA LTD. (INDIA)
Letrozol-fempro
“Letrozole” is the Drug / Molecule content in "Fempro". Letrozole is a nonsteroidal competitive inhibitor of the aromatase enzyme system; it inhibits the conversion of androgens to estrogen. It lowers estrogen levels in postmenopausal women, which slow growth of certain types of breast tumors that results estrogen to grow in the body.
Indication
Fempro is used for the treatment of breast cancer in postmenopausal women.
Note
Precaution
- Fempro is a prescription drug and should be used under proper medical guidance and advice. It is not recommended for use during pregnancy.
- Hot flushes, hair loss, joint/bone/muscle pain, tiredness, unusual sweating, nausea, diarrhoea, dizziness, and trouble sleeping may occur.
Updated On Oct 26, 2019 by Admin
Strength
2.5 mg
Packing
1 X 10 Tablets (Strip)
Storage
Store in a cool & dry place
Was this page helpful?
Related Products
NATCO PHARMA LIMITED (INDIA)
Anastronat
CIPLA LTD. (INDIA)
Anastrozole-armotraz
NATCO PHARMA LIMITED (INDIA)
Xtane
CIPLA LTD. (INDIA).
Armotraz
Most Viewed Products
CIPLA LTD. (INDIA)
Abiraterone acetate-xbira
NATCO PHARMA LIMITED (INDIA)
Bendamustine-bendit
CIPLA LTD. (INDIA)
Bicalutamide-cassotide
NATCO PHARMA LIMITED (INDIA)
Bortezomib-bortenat
NATCO PHARMA LIMITED (INDIA)
Erlonat
Biocon Limited
Everolimus-evertor
NATCO PHARMA LIMITED (INDIA)
Exemestane-xtane
NATCO PHARMA LIMITED (INDIA)
Geftinat
NATCO PHARMA LIMITED (INDIA)
Glatiramer acetate-glatimer
NATCO PHARMA LIMITED (INDIA)
Ledipasvir & sofosbuvir-hepcinat lp
NATCO PHARMA LIMITED (INDIA)
Lenalidomide-lenalid
NATCO PHARMA LIMITED (INDIA)
Pomalidomide-pomalid
NATCO PHARMA LIMITED (INDIA)
Sofosbuvir & velpatasvir-velpanat
NATCO PHARMA LIMITED (INDIA)
Sorafenib-sorafenat
CIPLA LTD. (INDIA)